Peled N, Roisman LC, Levison E, Dudnik J, et al. Neoadjuvant Osimertinib Followed by Sequential Definitive Radiation Therapy
and/or Surgery in Stage III Epidermal Growth Factor Receptor-Mutant Non-Small
Cell Lung Cancer: An Open-Label, Single-Arm, Phase 2 Study. Int J Radiat Oncol Biol Phys 2023;117:105-114.
PMID: 36925073